Clinical Trial Update: Efficacy of Tranexamic Acid (TXA) in Humerus ORIF [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tranexamic acid for humerus fracture repair with open reduction and internal fixation (ORIF) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fracture of the Humerus

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Conditions: Fracture Humerus | Phase 2 | Status: WITHDRAWN